Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Target price




08:22 / Tradegate WKN: A2PPB4 / Symbol: PSTI / Name: Pluristem Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
Your prediction

Pluristem Therapeutics Inc. Stock

Pluristem Therapeutics Inc. took a tumble today and lost -€0.046 (-3.350%).
The community is currently still undecided about Pluristem Therapeutics Inc. with 1 Buy predictions and 0 Sell predictions.
With a target price of €2.00 there is a hugely positive potential of 50.659% for Pluristem Therapeutics Inc. compared to the current price of €1.33.
Our community identified positive and negative aspects for Pluristem Therapeutics Inc. stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Pluristem Therapeutics Inc. stock. On the other hand our users think that "EBIT growth" could be a problem in the future.

Pros and Cons of Pluristem Therapeutics Inc. in the next few years

W********* I********* f** t** n*** y****
M***** P*******
C******** o* t** e**********
S********** s********
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Pluristem Therapeutics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Pluristem Therapeutics Inc. -3.350% -9.608% -20.169% -78.024% 5.573% - -
Enlivex Therapeutics Ltd. -2.470% -9.274% -18.919% -54.315% -12.621% - -
Oramed Pharmaceuticals 0.640% -17.992% -42.690% 72.878% -29.623% 152.090% 33.311%
Clovis Oncology Inc. -5.990% -21.759% -33.441% -66.114% -22.638% -90.874% -96.677%

Other discussions about Pluristem Therapeutics Inc. Stock

New thread Forum